Solvay, Unimed Sued Again Over AndroGel Deals

Law360, New York (May 20, 2009, 12:00 AM EDT) -- Solvay Pharmaceuticals Inc. has been sued again over allegedly illegal agreements with drugmakers including Watson Pharmaceuticals Inc. to keep generic versions of the testosterone drug AndroGel off the market — the seventh private suit concerning the deals since the Federal Trade Commission took Solvay to court in January.

The United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund filed a putative class action suit Tuesday in the U.S. District Court for the District of Minnesota, seeking to recover what it called overcharges stemming...
To view the full article, register now.